TM4SF1 and malignant pleural mesothelioma: Moreover, Studies have shown that TM4SF1 could serve as a predictor of post-surgical treatment efficacy in patients with malignant pleural mesothelioma (MPM), and patients with higher TM4SF1 expression levels have relatively good prognosis (Gordon et al., 2003, 2009, 2011).